Evidence mapPaperPMID 41620462Full record

ArticleScientific reports2026

Prevalence of diabetes/prediabetes and their associated risk factors among adults with hypertension from iran: a nationwide study.

Mina Mirzad, Ali Golestani, Sepehr Khosravi, Nazila Rezaei, Nekoo Panahi, Mojtaba Lotfaliany, Ozra Tabatabaei-Malazy

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mina Mirzad *Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ali Golestani *Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sepehr KhosraviNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Nazila RezaeiNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Nekoo PanahiMetabolic Disorders Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mojtaba Lotfalianythe Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Barwon Health, Geelong, VIC, Australia.
Ozra Tabatabaei-MalazyEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. tabatabaeiml@sina.tums.ac.ir.

Funding

Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences 1403-2-221-73074
6 · The paper itself

Abstract

The risk of cardiovascular diseases (CVDs) is significantly increased when diabetes mellitus and hypertension coexist. Improving the clinical management of people with hypertension requires understanding the prevalence of diabetes in these patients. We conducted a cross-sectional analysis of 5,935 adults with hypertension who participated in the STEPwise approach to non-communicable diseases (NCD) risk factor surveillance (STEPS) 2021 of Iran. Diabetes mellitus was defined as fasting plasma glucose ≥ 126 mg/dL or current use of anti-hyperglycemic medication. Prediabetes was defined as 100 ≤ FPG < 126 without current anti-hyperglycemic medication use. Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg, diastolic blood pressure (DBP) ≥ 90 mmHg, or a history of anti-hypertensive treatment. Using logistic regression, we found characteristics associated with diabetes prevalence, while linear regression assessed the impact of diabetes status on systolic and diastolic blood pressure. Survey weights were utilized to ensure representativeness. Among individuals with hypertension, 25.3% (95% CI: 23.69-26.92) had diabetes, and 29.7% (95% CI: 27.93-31.45) had prediabetes. Of the diabetic patients, 20.7% achieved good glycemic control, 50.3% had uncontrolled diabetes, 7.8% were untreated, and 21.2% were undiagnosed. Diabetes was significantly more prevalent in those with cardiovascular disease (adjusted odds ratio (AOR) = 1.45, 95% CI: 1.14-1.84), chronic renal disease (1.74, 1.42-2.14), and dyslipidemia (1.83, 1.23-2.72). A positive family history of diabetes was significantly strong predictor (3.06, 2.53-3.69). Older age, urban residency, higher waist circumference, better diet quality, and hypertension treatment were also associated with increased diabetes risk. DBP was significantly lower in individuals with controlled diabetes (expected mean difference (EMD)= -2.52, 95% CI: -4.6 to -0.44) and treated but uncontrolled diabetes (EMD - 2.13, -3.77 to -0.48), while SBP was significantly higher in individuals with undiagnosed diabetes (EMD 4.76, 0.28-9.24). Diabetes and prediabetes are common among people with hypertension, with significant gaps in glycemic control. Early detection and improved management of both blood pressure and blood sugar levels are essential to reduce the burden of CVDs. Public health initiatives must prioritize targeted interventions for high-risk groups to effectively enhance diabetes management among individuals with hypertension.

Indexed as

Diabetes MellitusHypertensionPrediabetic StateAdultAgedBlood PressureCross-Sectional StudiesFemaleHumansIranMaleMiddle AgedPrevalenceRisk FactorsCardiovascular diseaseDiabetes mellitusEpidemiologyHypertensionIranSTEPS survey

Identifiers

PMID41620462
PMCPMC12916925

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.